Alimentary Tract| Volume 49, ISSUE 1, P17-23, January 2017

Download started.


Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study”

Published:October 04, 2016DOI:



      Late-onset UC represents an important issue for the near future, but its outcomes and relative therapeutic strategies are yet poorly studied.


      To better define the natural history of late-onset ulcerative colitis.


      In a multicenter retrospective study, we investigated the disease presentation and course in the first 3 years in 1091 UC patients divided into 3 age-groups: diagnosis ≥65 years, 40–64 years, and <40 years. Disease patterns, medical and surgical therapies, and risk factors for disease outcomes were analyzed.


      Chronic active or relapsing disease accounts for 44% of patients with late-onset UC. Across all age-groups, these disease patterns require 3–6 times more steroids than remitting disease, but immunomodulators and, to a lesser extent, biologics are less frequently prescribed in the elderly. Advanced age, concomitant diseases and related therapies were found to be inversely associated with the use of immunomodulators or biologics, but not with surgery.


      The conclusion that late-onset UC follows a mild course may apply only to a subset of patients. an important percentage of elderly patients present with more aggressive disease. Since steroid use and surgery rates did not differ in this subgroup, lower use of immunosuppressive therapy and biologics may reflect concerns in prescribing these therapies in the elderly.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Charpentier C.
        • Salleron J.
        • Savoye G.
        • et al.
        Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
        Gut. 2014; 63: 423-432
        • Gower-Rousseau C.
        • Vasseur F.
        • Fumery M.
        • et al.
        Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).
        Digestive and Liver Disease. 2013; 45: 89-94
        • Loftus C.G.
        • Loftus Jr., E.V.
        • Harmsen W.S.
        • et al.
        Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000.
        Inflammatory Bowel Diseases. 2007; 13: 254-261
        • Stonnington C.M.
        • Phillips S.F.
        • Melton 3rd, L.J.
        • et al.
        Chronic ulcerative colitis: incidence and prevalence in a community.
        Gut. 1987; 28: 402-409
        • Jeuring S.F.
        • van den Heuvel T.R.
        • Zeegers M.P.
        • et al.
        Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age-an increasing distinct entity.
        Inflammatory Bowel Diseases. 2016; 22: 1425-1434
        • Baggenstos B.
        • Hanson B.
        • Shaukat A.
        Treatment of ulcerative colitis in the elderly: a systematic review.
        Clinical Medicine Insights: Geriatrics. 2013; 6: 1-26
        • Ha C.Y.
        • Newberry R.D.
        • Stone C.D.
        • Ciorba M.A.
        Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease.
        Clinical Gastroenterology and Hepatology. 2010; 8: 682-687
        • Duricova D.
        • Burisch J.
        • Jess T.
        • et al.
        Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.
        Journal of Crohn’s and Colitis. 2014; 8: 1351-1361
        • Cottone M.
        • Kohn A.
        • Daperno M.
        • et al.
        Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
        Clinical Gastroenterology and Hepatology. 2011; 9: 30-35
        • Lobaton T.
        • Ferrante M.
        • Rutgeerts P.
        • et al.
        Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.
        Alimentary Pharmacology Therapeutics. 2015; 42: 441-451
        • Beaugerie L.
        • Brousse N.
        • Bouvier A.M.
        • et al.
        Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
        The Lancet. 2009; 374: 1617-1625
        • Peyrin-Biroulet L.
        • Khosrotehrani K.
        • Carrat F.
        • et al.
        Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
        Gastroenterology. 2011; 141 (e1–e5): 1621-1628
        • Ananthakrishnan A.N.
        • McGinley E.L.
        • Binion D.G.
        Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations.
        Inflammatory Bowel Diseases. 2009; 15: 182-189
        • Sonnenberg A.
        Age distribution of IBD hospitalization.
        Inflammatory Bowel Diseases. 2010; 16: 452-457
        • Ventham N.T.
        • Kennedy N.A.
        • Duffy A.
        • et al.
        Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998–2000 and 2007–2009.
        Alimentary Pharmacology Therapeutics. 2014; 39: 1387-1397
        • Bernstein C.N.
        • Nugent Z.
        • Targownik L.E.
        • et al.
        Predictors and risks for death in a population-based study of persons with IBD in Manitoba.
        Gut. 2015; 64: 1403-1411
        • Ikeuchi H.
        • Uchino M.
        • Matsuoka H.
        • et al.
        Prognosis following emergency surgery for ulcerative colitis in elderly patients.
        Surgery Today. 2014; 44: 39-43
        • Nordenvall C.
        • Ekbom A.
        • Bottai M.
        • et al.
        Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study.
        Alimentary Pharmacology Therapeutics. 2014; 40: 280-287
        • Coakley B.
        • Telem D.
        • Nguyen S.
        • et al.
        Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis.
        Surgery. 2013; 153: 242-248
        • Lennard-Jones J.E.
        Classification of inflammatory bowel disease.
        Scandinavian Journal of Gastroenterology Supplement. 1989; 170: 2-6
        • Satsangi J.
        • Silverberg M.S.
        • Vermeire S.
        • et al.
        The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.
        Gut. 2006; 55: 749-753
        • Schroeder K.W.
        • Tremaine W.J.
        • Ilstrup D.M.
        Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.
        New England Journal of Medicine. 1987; 317: 1625-1629
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • et al.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        Journal of Chronic Diseases. 1987; 40: 373-383
        • Henriksen M.
        • Jahnsen J.
        • Lygren I.
        • et al.
        Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study).
        Inflammatory Bowel Diseases. 2006; 12: 543-550
        • Lakatos P.L.
        • David G.
        • Pandur T.
        • et al.
        IBD in the elderly population: results from a population-based study in Western Hungary, 1977–2008.
        Journal of Crohn’s and Colitis. 2011; 5: 5-13
        • Juneja M.
        • Baidoo L.
        • Schwartz M.B.
        • et al.
        Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.
        Digestive Diseases and Sciences. 2012; 57: 2408-2415
        • Carr N.
        • Schofield P.F.
        Inflammatory bowel disease in the older patient.
        British Journal of Surgery. 1982; 69: 223-225
        • Zimmerman J.
        • Gavish D.
        • Rachmilewitz D.
        Early and late onset ulcerative colitis: distinct clinical features.
        Journal of Clinical Gastroenterology. 1985; 7: 492-498
        • Jess T.
        • Riis L.
        • Vind I.
        • et al.
        Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
        Inflammatory Bowel Diseases. 2007; 13: 481-489
        • Targownik L.E.
        • Singh H.
        • Nugent Z.
        • et al.
        The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort.
        American Journal of Gastroenterology. 2012; 107: 1228-1235
        • Solberg I.C.
        • Lygren I.
        • Jahnsen J.
        • et al.
        Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
        Scandinavian Journal of Gastroenterology. 2009; 44: 431-440